江西马应龙美康药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
6
NMPA:6
Drug Approvals
Sodium Hyaluronate Eye Drops
- Product Name
- 玻璃酸钠滴眼液
- Approval Number
- 国药准字H20254427
- Approval Date
- Jun 3, 2025
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20244523
- Approval Date
- Jul 30, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20244360
- Approval Date
- Jun 28, 2024
NMPA
Compound Dextran 70 Eye Drops
- Product Name
- 复方右旋糖酐70滴眼液
- Approval Number
- 国药准字H20073639
- Approval Date
- Aug 4, 2022
NMPA
Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B12 Eye Drops
- Product Name
- 萘敏维滴眼液
- Approval Number
- 国药准字H20073217
- Approval Date
- May 15, 2022
NMPA
Clinical Trials
No trials found
News
No news found